The AIM and Small Cap companies page allows you to research and analyse as well as read the latest AIM and Small Cap news.
|FTSE Small Cap||4333||+14.89|
|FTSE AIM All-Share||697||+4.52|
|FTSE AIM 100||3066||+20.90|
|FTSE AIM 50||3439||+33.80|
|Moss Bros Group||89.00p||5.00p|
Entertainment product distributor MBL Group saw its pre-tax loss from continuing operation double in the first half of the year, on the back of rising costs and difficult trading conditions.
Tiziana Life Sciences has been granted an exclusive license to develop and commercialise Novimmune SA's CD3 receptor monoclonal antibody foralumab.